Technology provides a new way to probe single molecules

The powerful new approach, called individual ion mass spectrometry, or I2MS, can determine the exact mass of a huge range of intact proteins. It weighs each and every molecule on an individual basis. This ability promises to aid the understanding of disease and infection and accelerate the design of vaccines for deadly viruses, such as the coronavirus.

Details on this fundamentally new way to weigh single molecules of proteins or their assemblies, such as whole viruses, will be published March 2 by the journal Nature Methods.

The researchers show their method, which uses the commercially available Orbitrap mass analyzer system, can be used on super complex mixtures of intact proteins, and even whole virus particles carrying diverse cargo within them. This power and versatility will enable a new wave of molecular precision to be brought to diverse problems in vacinnology, virology, neurodegenerative plaques and disease biology in general.

"Quickly characterizing the masses of viruses and their infectious cargo over time may help scientists understand mutations that are occurring," said Neil L. Kelleher, who led the research.

"Whether directly characterizing different strains of viruses or profiling different vaccine formulations, our new technology now can be deployed directly on these protein-containing samples to pursue the most urgent challenges of the day," he said.

Kelleher is a pioneer in top-down proteomics with one of the leading groups in the world that studies intact proteins. He is the Walter and Mary Elizabeth Glass Chair in Life Sciences in the Weinberg College of Arts and Sciences' departments of chemistry and molecular biosciences.

The technology will help scientists further understand the composition of the exterior of a virus (called the capsid) and the infectious cargo held within the capsid, Kelleher said. Because the researchers can analyze a handful of single virus particles at a time, they can extract information about precise variations in each particle.

"Many research groups are studying the use of viral capsids filled with cargo as a means to deliver life-saving drugs to patients," said Jared O. Kafader, the study's first author. "Our technology provides a practical way to determine if the cargo contains the correct drug or to find out what is actually within each virus particle."

Kafader is a senior research associate in Northwestern's Proteomics Center of Excellence. (Proteomics is the study and analysis of protein structure and function.)

A related study by the Kelleher group, published recently in the Journal of Proteome Research, extends analysis of I2MS to fragmentation of intact species. By fragmenting intact proteins, important information about where modifications or mutations on the protein can be identified, the researchers said. These modifications have implications for understanding how proteins change or mutate in cancer patients.